-
IDWeek Highlights | Dr. Hong-mei Xu: Consistency Evaluation of Congenital CMV Infection in Dried Blood Spots and Plasma PCR Testing
Editor’s Note: Newborns can be infected with congenital cytomegalovirus (CMV) through vertical mother-to-child transmission, and CMV infection screening is required for some newborns with specific indications. Polymerase chain reaction (PCR)…
-
Dr. Chun-rong Ju: Lung Transplant Recipients Receive Prolonged Contezolid Treatment for Nocardia Infection
Editor’s note: Nocardia is a conditional pathogen, and infections are common in immunocompromised populations such as organ transplant recipients. Professor Chunrong Ju and her team at the First Affiliated Hospital…
-
IDWeek Commentary | Dr. Hongzhou Lu: Can ” Online Celebrity Weight Loss Drugs” Also Be Used for HIV-Infected Individuals?
Editor’s Note: “Experiencing weight gain due to medication” is a common concern for many people living with HIV (PLWH). Some antiretroviral therapy (ART) regimens are associated with weight gain and…
-
IDWeek Interview | Dr. Shields: Real-World Study on the Efficacy of Two Generation BL-BLI Combination Therapy for MDR-PA
Editor’s Note: Ceftolozane-tazobactam is a new BL-BLI combination drug, and ceftolozane is a third-generation cephalosporin antibiotic, and tazobactam is a beta-lactamase inhibitor. At the recent 2023 IDWeek in the United…
-
Can MRSA Surveillance Results Be Used to Discontinue Vancomycin for Infections Other Than Pneumonia?
Editor’s Note: At the IDWeek 2023, Dr. Rebekah W. Moehring from the Duke Center for Antimicrobial Stewardship and Infection Control at Duke University presented a fascinating report on the use…
-
IDWEEK Live Interview | Dr. Thomas L. Holland：Careful consideration when selecting clinical outcomes brings more possibilities to clinical trials of bacterial diseases
Editor’s Note: Staphylococcus aureus bacteremia is a major cause of bloodstream infections, and hospital-acquired bacterial pneumonia is often caused by multidrug-resistant bacteria. And developing new antibiotics requires patient-centered clinical outcomes.…
-
ESMO Live Update | Dr. Girard Analyzes PAPILLON: Opening New Doors for First-Line Treatment of EGFR Exon 20 Insertion Mutant Advanced NSCLC
Based on the results of the PAPILLON trial, presented at the 2023 ESMO Congress, a dual-specificity EGFR/MET monoclonal antibody has the potential to become a standard of care for EGFR exon 20 insertion mutant advanced or metastatic non-small cell lung cancer (NSCLC), although toxicity management must be approached with caution (Abstract LBA5). Dr. Nicolas Girard,…
-
ASCO China Voice | Professor Wu Yilong Reports Phase III EVEREST Trial Results at ASCO
The American Society of Clinical Oncology (ASCO) Annual Meeting was held in Chicago from June 2 to June 6, 2023. Oncology Insight delves into the forefront of the conference, inviting researchers to share the most prominent Chinese research at ASCO, witnessing the advancement of China’s anti-tumor efforts on the international stage. Professor Wu Yilong from…
Connecting Medical Expertise through Media